On the Diversity of Oxidative Bioactivation Reactions on Nitrogen- Containing Xenobiotics
Journal:
Current Drug Metabolism
Volume:
3
Page:
379-424
Author(s):
Amit S. Kalgutkar, Deepak K. Dalvie, John P. O'Donnell, Timothy J. Taylor and Diana C. Sahakian
A Prionogenic Peptide Derived from Sup35 can Force the Whole Gst Fusion Protein to Show Amyloid Characteristics
Journal:
Protein & Peptide Letters
Volume:
9
Page:
315-321
Author(s):
Young Kee Chae, Kyoung Suk Cho and Woochun Chun
Targeting the AMP-Activated Protein Kinase for the Treatment of Type 2 Diabetes
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
2
Page:
119-127
Author(s):
Nicolas Musi and Laurie J. Goodyear
Inhibitors of Post-Translational Modifications of G-Proteins as Probes to Study the Pancreatic β Cell Function: Potential Therapeutic Implications
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
2
Page:
129-139
Author(s):
A. Kowluru and R. Amin
Therapeutic Potential of the Mammalian Pyruvate Dehydrogenase Kinases in the Prevention of Hyperglycaemia
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
2
Page:
151-165
Author(s):
M. C. Sugden and M. J. Holness
Multiple Drug Targets in the Management of Type 2 Diabetes
Journal:
Current Drug Targets
Volume:
3
Page:
203-221
Author(s):
M.H. Moneva and S. Dagogo-Jack
Human Microdialysis
Journal:
Current Pharmaceutical Biotechnology
Volume:
3
Page:
165-178
Author(s):
M. Stahl, R. Bouw, A. Jackson and V. Pay
Annexins as Neuroprotective Agents in the Central Nervous System
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
2
Page:
87-107
Author(s):
Joanna Bandorowicz-Pikula
Measurement and Mapping of Retinal Leakage and Retinal Thickness - Surrogate Outcomes for the Initial Stages of Diabetic Retinopathy
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
2
Page:
91-108
Author(s):
J.G. Cunha-Vaz
Aspartic Proteinases in Disease: A Structural Perspective
Journal:
Current Drug Targets
Volume:
3
Page:
155-173
Author(s):
J. B. Cooper